Cure SMA Highlights Progress and Gaps in Spinal Muscular Atrophy Care as Awareness Month Begins
As August marks Spinal Muscular Atrophy (SMA) Awareness Month, Cure SMA is releasing its annual 'State of SMA' report. The report details progress and persistent gaps in care for over 9,000 individuals affected by the condition.
Schaumburg, Illinois – August marks Spinal Muscular Atrophy (SMA) Awareness Month, a time when Cure SMA, an organization dedicated to advancing research and care for those affected by the genetic neuromuscular disorder, is drawing attention to its annual "State of SMA" report. The 2025 report serves as a data-driven overview of the evolving landscape of SMA, impacting more than 9,000 individuals and families nationwide.
The report acknowledges significant advancements in diagnosis and treatment that have emerged in recent years, including the availability of new therapeutic options. However, as highlighted in the report released in December 2025, substantial challenges and disparities in access to care and comprehensive support persist for patients. Cure SMA aims to highlight these areas to improve the quality of life for individuals living with SMA.
According to Cure SMA, key areas requiring continued focus include ensuring early diagnosis, achieving equitable access to treatments across different regions, and providing necessary supportive care. The organization emphasizes that while new therapies have been developed, their effective implementation and ongoing patient monitoring necessitate further resources and coordinated efforts.
Spinal Muscular Atrophy is a rare genetic condition that affects motor neurons in the spinal cord, leading to muscle weakness and wasting. Cure SMA is committed to accelerating research and developing effective treatments and support services for those diagnosed with the disorder.